• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Huina, ZHANG Ke, MIAO Yan, et al. Progress in pharmaceutical crystallographic study of mannitol[J]. J China Pharm Univ, 2025, 56(2): 264 − 270. DOI: 10.11665/j.issn.1000-5048.2024110401
Citation: LIU Huina, ZHANG Ke, MIAO Yan, et al. Progress in pharmaceutical crystallographic study of mannitol[J]. J China Pharm Univ, 2025, 56(2): 264 − 270. DOI: 10.11665/j.issn.1000-5048.2024110401

Progress in pharmaceutical crystallographic study of mannitol

Funds: This study was supported by the National Natural Science Foundation of China (No.82104401, No.82274217, No.82204636, No.82373824)
More Information
  • Received Date: November 03, 2024
  • As a pharmaceutical excipient with low caloric value, low hygroscopicity, and high stability, mannitol is widely used in various dosage forms, such as solid, lyophilized and inhalation preparations, etc. It has different crystal structures (α, β and δ) and cocrystal, and the changes in the crystal structure will affect formulation properties of pharmaceutical formulations. This paper reviews structural features, physicochemical properties, and preparation methods of mannitol polymorphs and cocrystal formation, with emphasis on polymorphic transformation pathways, monitoring methods and the effect of polymorphic transformation on properties and application in pharmaceutical formulations, including tabletability, disintegration and dissolution properties. By systematically summarizing the crystallographic study of mannitol, this study attempts to provide new ideas for the development of novel pharmaceutical excipients and applications in pharmaceutical formulations.

  • [1]
    Yang YX, Liu J, Hu AN, et al. A critical review on engineering of d-mannitol crystals: properties, applications, and polymorphic control[J]. Crystals, 2022, 12(8): 1080-1101. doi: 10.3390/cryst12081080
    [2]
    Shao XF, Yang S, Fan LW, et al. Sugar alcohol phase change materials for low-to-medium temperature thermal energy storage: a comprehensive review[J]. J Energy Storage, 2023, 68: 107848. doi: 10.1016/j.est.2023.107848
    [3]
    Poka MS, Milne M, Wessels A, et al. Sugars and polyols of natural origin as carriers for solubility and dissolution enhancement[J]. Pharmaceutics, 2023, 15(11): 2557-2585. doi: 10.3390/pharmaceutics15112557
    [4]
    Farfan Pajuelo DG, Carpio Mamani M, Maraza Choque GJ, et al. Effect of lyoprotective agents on the preservation of survival of a bacillus cereus strain PBG in the freeze-drying process[J]. Microorganisms, 2023, 11(11): 2705-2722. doi: 10.3390/microorganisms11112705
    [5]
    Drago SE, Cabibbo M, Craparo EF, et al. TAT decorated si-RNA polyplexes for inhalation delivery in anti-asthma therapy[J]. Eur J Pharm Sci, 2023, 190: 106580. doi: 10.1016/j.ejps.2023.106580
    [6]
    Thakral S, Sonje J, Munjal B, et al. Mannitol as an excipient for lyophilized injectable formulations[J]. J Pharm Sci, 2023, 112(1): 19-35. doi: 10.1016/j.xphs.2022.08.029
    [7]
    Cheng H, Wei YF, Wang SR, et al. Improving tabletability of excipients by metal-organic framework-based cocrystallization: a study of mannitol and CaCl2[J]. Pharm Res, 2020, 37(7): 130-144. doi: 10.1007/s11095-020-02850-8
    [8]
    Sonje J, Thakral S, Mayhugh B, et al. Mannitol hemihydrate in lyophilized protein formulations: impact of its dehydration during storage on sucrose crystallinity and protein stability[J]. Int J Pharm, 2022, 624: 121974. doi: 10.1016/j.ijpharm.2022.121974
    [9]
    Thakral S, Sonje J, Suryanarayanan R. Anomalous behavior of mannitol hemihydrate: implications on sucrose crystallization in colyophilized systems[J]. Int J Pharm, 2020, 587: 119629. doi: 10.1016/j.ijpharm.2020.119629
    [10]
    Saha BK, Nath NK, Thakuria R. Polymorphs with remarkably distinct physical and/or chemical properties[J]. Chem Rec, 2023, 23(1): 202200173. doi: 10.1002/tcr.202200173
    [11]
    Braga D, Casali L, Grepioni F. The relevance of crystal forms in the pharmaceutical field: sword of damocles or innovation tools?[J]. Int J Mol Sci, 2022, 23(16): 9013-9042. doi: 10.3390/ijms23169013
    [12]
    Vanhoorne V, Almey R, De Beer T, et al. Delta-mannitol to enable continuous twin-screw granulation of a highly dosed, poorly compactable formulation[J]. Int J Pharm, 2020, 583: 119374. doi: 10.1016/j.ijpharm.2020.119374
    [13]
    Burger A, Henck JO, Hetz S, et al. Energy/temperature diagram and compression behavior of the polymorphs of d-mannitol[J]. J Pharm Sci, 2000, 89(4): 457-468. doi: 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G
    [14]
    Yu L, Huang J, Jones KJ. Measuring free-energy difference between crystal polymorphs through eutectic melting[J]. J Phys Chem B, 2005, 109(42): 19915-19922. doi: 10.1021/jp053653g
    [15]
    Cornel J, Kidambi P, Mazzotti M. Precipitation and transformation of the three polymorphs of d-mannitol[J]. Ind Eng Chem Res, 2010, 49(12): 5854-5862. doi: 10.1021/ie9019616
    [16]
    Su W, Liu J, Wang H, et al. Thermodynamic study of three anhydrous polymorphs of d-mannitol in different binary solvent mixtures from T = (258.15 to 278.15) K[J]. J Chem Thermodyn, 2020, 141: 105680. doi: 10.1016/j.jct.2019.01.005
    [17]
    Mareczek L, Riehl C, Harms M, et al. Understanding the multidimensional effects of polymorphism, particle size and processing for d-mannitol powders[J]. Pharmaceutics, 2022, 14(10): 2128-2147. doi: 10.3390/pharmaceutics14102128
    [18]
    Wagner CM, Pein M, Breitkreutz J. Roll compaction of granulated mannitol grades and the unprocessed crystalline delta-polymorph[J]. Powder Technol, 2015, 270: 470-475. doi: 10.1016/j.powtec.2014.03.073
    [19]
    Chettri A, Subba A, Singh GP, et al. Pharmaceutical co-crystals: a green way to enhance drug stability and solubility for improved therapeutic efficacy[J]. J Pharm Pharmacol, 2023: rgad097.
    [20]
    Liu J, Klinzing GR, Nie H. Effect of material properties and variability of mannitol on tablet formulation development[J]. Pharm Res, 2023, 40(8): 2071-2085. doi: 10.1007/s11095-023-03577-y
    [21]
    Zhang JJ, Zhang ZF, Cheng H, et al. Mannitol calcium bromide cocrystal and its preparation method and application: CN112110795A[P]. 2020-12-22.
    [22]
    Peng W, Lin Z, Cao W, et al. Crystal defects creation in mannitol@CaCl2 metal–organic framework by induced dehydration strategy for enhanced excipient mechanical properties[J]. Int J Pharm, 2024, 652: 123837. doi: 10.1016/j.ijpharm.2024.123837
    [23]
    Wen X, Wang S, Ramji R, et al. Complete inhibition of a polyol nucleation by a micromolar biopolymer additive[J]. Cell Rep Phys Sci, 2022, 3(2): 100723. doi: 10.1016/j.xcrp.2021.100723
    [24]
    Penha FM, Gopalan A, Meijlink JC, et al. Selective crystallization of d-mannitol polymorphs using surfactant self-assembly[J]. Cryst Growth Des, 2021, 21(7): 3928-3935. doi: 10.1021/acs.cgd.1c00243
    [25]
    Abdullahi H, Neoptolemou P, Burcham CL, et al. Single droplets to particles-size, shape, shell thickness and porosity analyses using X-ray computed tomography[J]. Chem Eng Sci, 2021, 245: 116879. doi: 10.1016/j.ces.2021.116879
    [26]
    Badal Tejedor M, Fransson J, Millqvist Fureby A. Freeze-dried cake structural and physical heterogeneity in relation to freeze-drying cycle parameters[J]. Int J Pharm, 2020, 590: 119891. doi: 10.1016/j.ijpharm.2020.119891
    [27]
    Su WY, Zhang Y, Liu JM, et al. Molecular dynamic simulation of d-mannitol polymorphs in solid state and in solution relating with spontaneous nucleation[J]. J Pharm Sci, 2020, 109(4): 1537-1546. doi: 10.1016/j.xphs.2020.01.012
    [28]
    Yao CL, Zhang SF, Wang L, et al. Recent advances in polymorph discovery methods of organic crystals[J]. Cryst Growth Des, 2023, 23(1): 637-654. doi: 10.1021/acs.cgd.2c00960
    [29]
    Tang X, Ryu J. Polymorphism of d-mannitol in zeolite-added d-mannitol-based phase change materials and its effect on supercooling degree[J]. Int J Thermophys, 2023, 44(4): 58-76. doi: 10.1007/s10765-023-03171-9
    [30]
    Neumann H, Niedermaier S, Gschwander S, et al. Cycling stability of d-mannitol when used as phase change material for thermal storage applications[J]. Thermochimica Acta, 2018, 660: 134-143. doi: 10.1016/j.tca.2017.12.026
    [31]
    Altay Benetti A, Bianchera A, Buttini F, et al. Mannitol polymorphs as carrier in DPIs formulations: isolation characterization and performance[J]. Pharmaceutics, 2021, 13(8): 1113-1134. doi: 10.3390/pharmaceutics13081113
    [32]
    De Pauw E, Vervaet C, Vanhoorne V. Formation of delta-mannitol by co-spray drying: enhancing the tabletability of paracetamol/mannitol formulations[J]. J Drug Deliv Sci Technol, 2022, 77: 103907. doi: 10.1016/j.jddst.2022.103907
    [33]
    Gao Y, Cheng H, Wang S, et al. Mannitol cocrystal excipient and its preparation method and use: CN111166891B[P]. 2022-04-05.
    [34]
    Gao Y, Li ZD, Zhang ZF, et al. A preparation method suitable for industrial scale-up production of mannitol cocrystal excipients: CN113788849A[P]. 2021-12-14.
    [35]
    Park H, Kim JS, Hong S, et al. Tableting process-induced solid-state polymorphic transition[J]. J Pharm Investig, 2022, 52(2): 175-194. doi: 10.1007/s40005-021-00556-6
    [36]
    Shi Q, Chen HB, Wang YN, et al. Recent advances in drug polymorphs: aspects of pharmaceutical properties and selective crystallization[J]. Int J Pharm, 2022, 611: 121320. doi: 10.1016/j.ijpharm.2021.121320
    [37]
    Bruni G, Berbenni V, Milanese C, et al. Physico-chemical characterization of anhydrous d-mannitol[J]. J Therm Anal, 2009, 95(3): 871-876. doi: 10.1007/s10973-008-9384-5
    [38]
    Dierks TM, Korter TM. Origins of the relative stabilities of anhydrous and hydrated d-mannitol crystals[J]. J Phys Chem A, 2016, 120(33): 6629-6636. doi: 10.1021/acs.jpca.6b05244
    [39]
    Buanz A, Gurung M, Gaisford S. Crystallisation in printed droplets: understanding crystallisation of d-mannitol polymorphs[J]. CrystEngComm, 2019, 21(13): 2212-2219. doi: 10.1039/C8CE01780H
    [40]
    Zhu Y, Lu MJ, Gao F, et al. Role of tailor-made additives in crystallization from solution: a review[J]. Ind Eng Chem Res, 2023, 62(12): 4800-4816. doi: 10.1021/acs.iecr.2c04025
    [41]
    Yoshinari T, Forbes RT, York P, et al. Moisture induced polymorphic transition of mannitol and its morphological transformation[J]. Int J Pharm, 2002, 247(1): 69-77.
    [42]
    Descamps M, Willart JF, Dudognon E, et al. Transformation of pharmaceutical compounds upon milling and comilling: the role of Tg[J]. J Pharm Sci, 2007, 96(5): 1398-1407. doi: 10.1002/jps.20939
    [43]
    Martinetto P, Bordet P, Descamps M, et al. Structural transformations of d-mannitol induced by in situ milling using real time powder synchrotron radiation diffraction[J]. Cryst Growth Des, 2017, 17(11): 6111-6122. doi: 10.1021/acs.cgd.7b01283
    [44]
    Pinto JT, Zellnitz S, Guidi T, et al. Spray-congealing and wet-sieving as alternative processes for engineering of inhalation carrier particles: comparison of surface properties, blending andin vitro performance[J]. Pharm Res, 2021, 38(6): 1107-1123. doi: 10.1007/s11095-021-03061-5
    [45]
    Valentin M, Coibion D, Vertruyen B, et al. Macroporous mannitol granules produced by spray drying and sacrificial templating[J]. Materials, 2023, 16(1): 25-41.
    [46]
    Acevedo D, Wu WL, Yang X, et al. Evaluation of focused beam reflectance measurement (FBRM) for monitoring and predicting the crystal size of carbamazepine in crystallization processes[J]. CrystEngComm, 2021, 23(4): 972-985. doi: 10.1039/D0CE01388A
    [47]
    O'sullivan B, Glennon B. Application ofin situ FBRM and ATR-FTIR to the monitoring of the polymorphic transformation of d-mannitol[J]. Org Process Res Dev, 2005, 9(6): 884-889. doi: 10.1021/op0500887
    [48]
    Su WY, Hao HX, Barrett M, et al. The impact of operating parameters on the polymorphic transformation of d-mannitol characterized in situ with Raman spectroscopy, FBRM, and PVM[J]. Org Process Res Dev, 2010, 14(6): 1432-1437. doi: 10.1021/op100228f
    [49]
    Yoshinari T, Forbes RT, York P, et al. The improved compaction properties of mannitol after a moisture-induced polymorphic transition[J]. Int J Pharm, 2003, 258(1): 121-131.
    [50]
    Megarry A, Taylor A, Gholami A, et al. Twin-screw granulation and high-shear granulation: the influence of mannitol grade on granule and tablet properties[J]. Int J Pharm, 2020, 590: 119890. doi: 10.1016/j.ijpharm.2020.119890
    [51]
    Li GX, Gu WW, Li KK. Application of delta-mannitol in oral solid preparations after physical modification[J]. Guangdong Chem Ind (广东化工), 2022, 49(13): 44-46.
    [52]
    Zajc N, Obreza A, Bele M, et al. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method[J]. Int J Pharm, 2005, 291(1): 51-58.
    [53]
    Lenschow ICS, Bazzo GC, Zétola M, et al. Ball-milled valsartan and its combination with mannitol: the case of drug polyamorphism[J]. J Therm Anal, 2022, 147(16): 8765-8777. doi: 10.1007/s10973-021-11164-9
    [54]
    Cares-Pacheco MG, Vaca-Medina G, Calvet R, et al. Physicochemical characterization of d-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region[J]. Int J Pharm, 2014, 475(1): 69-81.
    [55]
    Han J, Li L, Su M, et al. Deaggregation and crystallization inhibition by small amount of polymer addition for a co-amorphous curcumin-magnolol system[J]. Pharmaceutics, 2021, 13(10): 1725-1749. doi: 10.3390/pharmaceutics13101725
  • Related Articles

    [1]JIANG Yun, LEI Yajuan, XIE Yingying, SHI Rong, LIU Yanming. Screening of 12 elemental impurities in pharmaceutical excipient grades of titanium dioxide from various sources and their correlations with whiteness[J]. Journal of China Pharmaceutical University, 2024, 55(6): 750-757. DOI: 10.11665/j.issn.1000-5048.2023122803
    [2]MIAO Yan, HU Liqin, ZHANG Ke, QIAN Shuai, GAO Yuan, ZHANG Jianjun, WEI Yuanfeng. Advances in research on the application of pharmaceutical excipients in traditional Chinese medicine preparations[J]. Journal of China Pharmaceutical University, 2024, 55(6): 734-741. DOI: 10.11665/j.issn.1000-5048.2024082902
    [3]WANG Huijian, WANG Yanfei, SU Wei, FU Qiang. Effects of pharmaceutical excipients on drug supersaturation in amorphous solid dispersions[J]. Journal of China Pharmaceutical University, 2024, 55(6): 725-733. DOI: 10.11665/j.issn.1000-5048.2023123001
    [4]SUN Chunmeng. Evolution in pharmacopoeia and practical significance of pharmaceutical excipients and the requirements of their functionality[J]. Journal of China Pharmaceutical University, 2024, 55(6): 721-724. DOI: 10.11665/j.issn.1000-5048.2024112101
    [5]SUN Chunmeng, CHEN Lei, LI Yanan, SONG Zonghua, YANG Zhaopeng, TU Jiasheng. Interpretation of the Guideline for Pharmaceutical Excipients of Animal Origin[J]. Journal of China Pharmaceutical University, 2022, 53(3): 376-382. DOI: 10.11665/j.issn.1000-5048.20220316
    [6]LI Haoyu, TANG Baoqiang, HE Dongsheng, TU Jiasheng. Determination of residual impurities in pharmaceutical excipient cetomacrogol 1000 by gas chromatography[J]. Journal of China Pharmaceutical University, 2022, 53(3): 293-299. DOI: 10.11665/j.issn.1000-5048.20220306
    [7]YI Chenchen, SHA Ruilin, CHEN Qinying, XIONG Yerong, TU Jiasheng. Quality study of pharmaceutical excipient polysorbate 80[J]. Journal of China Pharmaceutical University, 2020, 51(2): 168-174. DOI: 10.11665/j.issn.1000-5048.20200206
    [8]MA Kun, GAO Jing, MA Lei. Pharmaceutical cocrystals and salts[J]. Journal of China Pharmaceutical University, 2012, 43(5): 475-480.
    [9]Molecular Interaction in Solvents Between Water Insoluble Drug Nitrazepam and Pharmaceutical Excipients[J]. Journal of China Pharmaceutical University, 1998, (6): 408-412.
    [10]Investigation of the Polymorphism of Cefuroxime Axetil[J]. Journal of China Pharmaceutical University, 1997, (1): 23-27.

Catalog

    Article views (96) PDF downloads (35) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return